Cargando…
‘Ivabradin’ versus ‘Carvedilol’ in the management of Post-COVID-19 palpitation with sinus tachycardia
Autores principales: | Jadhav, Kartik, Jariwala, Pankaj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier, a division of RELX India, Pvt. Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718803/ http://dx.doi.org/10.1016/j.ihj.2020.11.092 |
Ejemplares similares
-
Potential Additive Effects of Ticagrelor, Ivabradine, and Carvedilol on Sinus Node
por: Di Serafino, Luigi, et al.
Publicado: (2014) -
Resolution of Sinus Tachycardia Secondary to Hyperthyroidism With Ivabradine
por: Medina, Yelizaveta, et al.
Publicado: (2023) -
Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine
por: Sağ, Saim, et al.
Publicado: (2016) -
Comparison of Effects of Ivabradine versus Carvedilol in Murine Model with the Coxsackievirus B3-Induced Viral Myocarditis
por: Yue-Chun, Li, et al.
Publicado: (2012) -
Ivabradine for junctional ectopic tachycardia in post congenital heart surgery
por: Kumar, Vivek, et al.
Publicado: (2017)